If so, the congressman asked, “Why persist in the dehumanizing of nascent human life when better alternatives exist, alternatives that work on both ethics grounds and efficacy grounds. Non-embryonic stem cell research is the present and it is the future of regenerative medicine, and the only responsible way forward.”
Rep. Smith went on to list several non-embryonic stem cell breakthroughs that were reported by mainstream media including articles from Reuters, the New York Times and the Associated Press.
“For example, on November 21, 2007 Reuters reported, and I quote, ‘Two separate teams of researchers announced on Tuesday they had transformed ordinary skin cells into batches of cells that look and act like embryonic stem cells, but without using cloning technology and without making embryos.’”
Rep. Smith also referred to a New York Times article from the same day: “Two teams of scientists reported yesterday that they had turned human skin cells into what appear to be embryonic stem cells without having to make or destroy an embryo—a feat that could quell the ethical debate troubling the field.”
The Associated Press said, “Scientists have created the equivalent of embryonic stem cells from ordinary skin cells, a breakthrough that could someday produce new treatments for diseases without the explosive moral questions of embryo cloning.”
(Story continues below)
Subscribe to our daily newsletter
The congressmen also mentioned other publications such as the Detroit Free Press, the Washington Post, and Medical News Today, which have lauded the scientific progress made using non-embryonic stem cells.
Citing the latest news on the iPS front, from the scientific journal, Nature, Rep. Smith recalled “that they had successfully reprogrammed ordinary skin cells into induced pluripotent skin cells without the use of viruses to transmit the reprogramming genes to the cell.” By “using a ‘piggyback’ system, as they called it, the scientists were able to insert DNA where they could alter the genetic make-up of the regular cell before being harmlessly removed.”
“According to many scientists,” Smith explained, “the removal of potentially cancer-causing viruses means this breakthrough increases the likelihood that iPS cells will be safe for clinical use in human patients. The lead scientist from Canada, Andras Nagy, was quoted in the Washington Post saying, ‘It's a leap forward in the safe application of these cells. We expect this to have a massive impact on this field’.”